Sotrovimab-resistant covid ‘could spread’

From The Medical Republic, 10 March 2022: Covid can develop resistance to the monoclonal antibody that was thought to be “variant-proof”, Australian research suggests. A research letter published in the New England Journal of Medicine reports on four patients with covid who experienced treatment failure with sotrovimab, and were then found to have variants of Continue reading Sotrovimab-resistant covid ‘could spread’